Drug
Burosumab
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Restless Legs Syndrome | 276 | 51.1 | 53.4 | signal |
| 2 | Tooth Abscess | 121 | 39.8 | 40.5 | signal |
| 3 | Contraindicated Product Administered | 190 | 21.0 | 21.7 | signal |
| 4 | Inappropriate Schedule Of Product Administration | 708 | 13.3 | 14.9 | signal |
| 5 | Incorrect Route Of Product Administration | 65 | 12.9 | 13.0 | signal |
| 6 | Bone Pain | 209 | 11.9 | 12.2 | signal |
| 7 | Dental Caries | 35 | 10.5 | 10.6 | signal |
| 8 | Toothache | 52 | 9.6 | 9.6 | signal |
| 9 | Pharyngitis Streptococcal | 31 | 9.5 | 9.6 | signal |
| 10 | Knee Operation | 26 | 8.9 | 8.9 | signal |
| 11 | Therapy Interrupted | 180 | 8.7 | 8.9 | signal |
| 12 | Injection Site Pruritus | 157 | 7.8 | 8.0 | signal |
| 13 | Injection Site Urticaria | 57 | 7.8 | 7.9 | signal |
| 14 | Product Dose Omission Issue | 645 | 7.5 | 8.3 | signal |
| 15 | Product Dose Omission | 140 | 7.0 | 7.2 | signal |
| 16 | Blood Alkaline Phosphatase Increased | 51 | 6.8 | 6.9 | signal |
| 17 | Ear Infection | 53 | 6.6 | 6.7 | signal |
| 18 | Sars-cov-2 Test Positive | 26 | 6.5 | 6.5 | signal |
| 19 | Tooth Fracture | 21 | 6.3 | 6.4 | signal |
| 20 | Tooth Infection | 25 | 6.3 | 6.3 | signal |
| 21 | Insurance Issue | 28 | 6.3 | 6.3 | signal |
| 22 | Spinal Pain | 21 | 6.0 | 6.0 | signal |
| 23 | Hypercalcaemia | 22 | 5.9 | 5.9 | signal |
| 24 | Vitamin D Deficiency | 17 | 5.8 | 5.8 | signal |
| 25 | Injection Site Rash | 48 | 5.3 | 5.3 | signal |
| 26 | Injection Site Mass | 58 | 5.2 | 5.3 | signal |
| 27 | Laboratory Test Abnormal | 46 | 5.2 | 5.2 | signal |
| 28 | Gastroenteritis Viral | 27 | 5.0 | 5.0 | signal |
| 29 | Tooth Extraction | 18 | 4.8 | 4.8 | signal |
| 30 | Joint Stiffness | 37 | 4.7 | 4.7 | signal |
| 31 | Foot Deformity | 15 | 4.5 | 4.5 | signal |
| 32 | Tooth Disorder | 30 | 4.5 | 4.5 | signal |
| 33 | Joint Dislocation | 14 | 4.4 | 4.4 | signal |
| 34 | Spinal Operation | 16 | 4.4 | 4.4 | signal |
| 35 | Illness | 123 | 4.1 | 4.1 | signal |
| 36 | Pain In Extremity | 353 | 4.0 | 4.2 | signal |
| 37 | Injection Site Reaction | 82 | 4.0 | 4.0 | signal |
| 38 | Injection Site Irritation | 15 | 3.9 | 3.9 | signal |
| 39 | Injection Site Erythema | 144 | 3.9 | 3.9 | signal |
| 40 | Injection Site Swelling | 87 | 3.8 | 3.9 | signal |
| 41 | Incorrect Dose Administered | 252 | 3.7 | 3.8 | signal |
| 42 | Product Administration Error | 22 | 3.7 | 3.7 | signal |
| 43 | Surgery | 61 | 3.5 | 3.5 | signal |
| 44 | Nephrolithiasis | 48 | 3.5 | 3.5 | signal |
| 45 | Ligament Sprain | 10 | 3.4 | 3.4 | signal |
| 46 | Covid-19 | 179 | 3.4 | 3.4 | signal |
| 47 | Therapeutic Response Shortened | 31 | 3.2 | 3.2 | signal |
| 48 | Injection Site Bruising | 76 | 3.2 | 3.2 | signal |
| 49 | Lower Limb Fracture | 18 | 3.1 | 3.1 | signal |
| 50 | Drug Effect Less Than Expected | 13 | 3.1 | 3.1 | signal |
| 51 | Arthralgia | 376 | 3.0 | 3.1 | signal |
| 52 | Musculoskeletal Discomfort | 15 | 2.9 | 2.9 | signal |
| 53 | Tenderness | 9 | 2.9 | 2.9 | signal |
| 54 | Seasonal Allergy | 12 | 2.8 | 2.8 | signal |
| 55 | Injection Site Warmth | 17 | 2.7 | 2.7 | signal |
| 56 | Back Pain | 189 | 2.7 | 2.8 | signal |
| 57 | Injection Site Pain | 243 | 2.7 | 2.7 | signal |
| 58 | Blood Calcium Decreased | 9 | 2.6 | 2.7 | signal |
| 59 | Influenza | 87 | 2.6 | 2.6 | signal |
| 60 | Musculoskeletal Stiffness | 67 | 2.5 | 2.6 | signal |
| 61 | Product Prescribing Error | 18 | 2.5 | 2.5 | signal |
| 62 | Fracture | 14 | 2.5 | 2.5 | signal |
| 63 | Exposure During Pregnancy | 45 | 2.4 | 2.4 | signal |
| 64 | Tooth Loss | 15 | 2.4 | 2.4 | signal |
| 65 | Weight Fluctuation | 7 | 2.2 | 2.2 | no signal |
| 66 | Therapy Partial Responder | 10 | 2.2 | 2.2 | signal |
| 67 | Hip Arthroplasty | 10 | 2.2 | 2.2 | signal |
| 68 | Pain | 391 | 2.1 | 2.2 | signal |
| 69 | Migraine | 60 | 2.1 | 2.1 | signal |
| 70 | Limb Discomfort | 19 | 2.0 | 2.0 | signal |
| 71 | Gout | 11 | 2.0 | 2.0 | signal |
| 72 | Deafness | 16 | 2.0 | 2.0 | signal |
| 73 | Hospitalisation | 88 | 1.9 | 1.9 | no signal |
| 74 | Neck Pain | 32 | 1.9 | 1.9 | no signal |
| 75 | Weight Increased | 124 | 1.8 | 1.9 | no signal |
| 76 | Muscle Spasms | 101 | 1.8 | 1.8 | no signal |
| 77 | Myalgia | 89 | 1.7 | 1.7 | no signal |
| 78 | Crying | 19 | 1.7 | 1.7 | no signal |
| 79 | Product Use In Unapproved Indication | 125 | 1.7 | 1.7 | no signal |
| 80 | Osteomyelitis | 9 | 1.7 | 1.7 | no signal |
| 81 | Glomerular Filtration Rate Decreased | 6 | 1.6 | 1.6 | no signal |
| 82 | Sluggishness | 5 | 1.6 | 1.6 | no signal |
| 83 | Injection Site Discomfort | 5 | 1.6 | 1.6 | no signal |
| 84 | Femur Fracture | 15 | 1.6 | 1.6 | no signal |
| 85 | Brain Fog | 7 | 1.6 | 1.6 | no signal |
| 86 | Foot Fracture | 9 | 1.6 | 1.6 | no signal |
| 87 | Adverse Event | 43 | 1.5 | 1.6 | no signal |
| 88 | Mobility Decreased | 33 | 1.5 | 1.5 | no signal |
| 89 | Pain In Jaw | 13 | 1.5 | 1.5 | no signal |
| 90 | Bedridden | 6 | 1.5 | 1.5 | no signal |
| 91 | Injection Site Nodule | 5 | 1.5 | 1.5 | no signal |
| 92 | Overdose | 97 | 1.5 | 1.5 | no signal |
| 93 | Product Availability Issue | 10 | 1.5 | 1.5 | no signal |
| 94 | Treatment Noncompliance | 24 | 1.5 | 1.5 | no signal |
| 95 | Conjunctivitis | 8 | 1.4 | 1.4 | no signal |
| 96 | Muscle Tightness | 7 | 1.4 | 1.4 | no signal |
| 97 | Muscle Twitching | 10 | 1.4 | 1.4 | no signal |
| 98 | Knee Arthroplasty | 9 | 1.4 | 1.4 | no signal |
| 99 | Product Storage Error | 37 | 1.4 | 1.4 | no signal |
| 100 | Blood Test Abnormal | 6 | 1.4 | 1.4 | no signal |
| 101 | Spinal Disorder | 4 | 1.4 | 1.4 | no signal |
| 102 | Accident | 5 | 1.4 | 1.4 | no signal |
| 103 | Nasopharyngitis | 76 | 1.4 | 1.4 | no signal |
| 104 | Coeliac Disease | 4 | 1.4 | 1.4 | no signal |
| 105 | Injection Site Extravasation | 5 | 1.3 | 1.3 | no signal |
| 106 | Tendonitis | 6 | 1.3 | 1.3 | no signal |
| 107 | Abscess | 6 | 1.2 | 1.2 | no signal |
| 108 | Wrong Technique In Product Usage Process | 75 | 1.2 | 1.2 | no signal |
| 109 | Intestinal Perforation | 4 | 1.2 | 1.2 | no signal |
| 110 | Upper Limb Fracture | 7 | 1.2 | 1.2 | no signal |
| 111 | Neoplasm | 4 | 1.2 | 1.2 | no signal |
| 112 | Anosmia | 5 | 1.1 | 1.1 | no signal |
| 113 | Underdose | 24 | 1.1 | 1.1 | no signal |
| 114 | Product Packaging Issue | 3 | 1.1 | 1.1 | no signal |
| 115 | Adverse Reaction | 4 | 1.0 | 1.0 | no signal |
| 116 | Blood Glucose Fluctuation | 3 | 0.9 | 0.9 | no signal |
| 117 | Abortion Spontaneous | 10 | 0.8 | 0.8 | no signal |
| 118 | Injection Site Discolouration | 3 | 0.8 | 0.8 | no signal |
| 119 | Multiple Fractures | 4 | 0.8 | 0.8 | no signal |
| 120 | Abnormal Weight Gain | 3 | 0.8 | 0.8 | no signal |
| 121 | Amenorrhoea | 4 | 0.8 | 0.8 | no signal |
| 122 | Product Dispensing Error | 5 | 0.8 | 0.8 | no signal |
| 123 | Dysmenorrhoea | 3 | 0.8 | 0.8 | no signal |
| 124 | Syringe Issue | 4 | 0.8 | 0.8 | no signal |
| 125 | Menstruation Irregular | 6 | 0.8 | 0.8 | no signal |
| 126 | Hair Texture Abnormal | 3 | 0.7 | 0.7 | no signal |
| 127 | Drug Effective For Unapproved Indication | 5 | 0.6 | 0.6 | no signal |
| 128 | Acne | 12 | 0.5 | 0.5 | no signal |
| 129 | Intentional Self-injury | 3 | 0.5 | 0.5 | no signal |
| 130 | Injection Site Haemorrhage | 7 | 0.3 | 0.3 | no signal |